Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
MYX Mayne Pharma Group	AU$4.67	-5.7%	-26.3%	AU$379.0m	AU$6.10	PB0.8x	E111.4%	n/a
BOT Botanix Pharmaceuticals	AU$0.40	2.6%	132.4%	AU$717.9m	n/a	PS346.9x	E99.4%	n/a
TRJ Trajan Group Holdings	AU$1.10	5.3%	-8.0%	AU$166.7m	AU$1.45	PS1.1x	E98.8%	n/a
GSS Genetic Signatures	AU$0.63	-8.0%	50.0%	AU$143.1m	AU$1.10	PS10.4x	E98.6%	n/a
MVP Medical Developments International	AU$0.41	0%	-45.3%	AU$45.6m	AU$2.94	PS1.4x	E93.1%	0%
ACR Acrux	AU$0.033	-5.7%	-23.3%	AU$9.6m	n/a	PS1.9x	E91.8%	0%
BDX BCAL Diagnostics	AU$0.095	3.3%	-4.0%	AU$34.1m	n/a	PS11x	E90.6%	n/a
CYP Cynata Therapeutics	AU$0.21	20.0%	75.0%	AU$37.9m	n/a	PS16.4x	E72.9%	n/a
OPT Opthea	AU$0.76	16.9%	27.7%	AU$935.6m	n/a	PS2227x	E63.4%	n/a
VFY Vitrafy Life Sciences	AU$1.75	6.1%	n/a	AU$111.7m	AU$2.36	PS3006.4x	E62.7%	n/a
MSB Mesoblast	AU$2.55	28.8%	779.3%	AU$2.9b	AU$1.86	PS307.3x	E61.2%	n/a
ARX Aroa Biosurgery	AU$0.74	9.6%	-11.4%	AU$255.2m	n/a	PS3.7x	E59.7%	n/a
IMU Imugene	AU$0.036	-5.3%	-65.7%	AU$267.7m	n/a	PS53.9x	E53.4%	n/a
ALA Arovella Therapeutics	AU$0.17	0%	47.8%	AU$180.1m	n/a	PS92.3x	E47.2%	n/a
TLX Telix Pharmaceuticals	AU$25.02	-2.8%	156.1%	AU$8.4b	AU$25.62	PE170.3x	E38.3%	n/a
PYC PYC Therapeutics	AU$1.40	-6.7%	27.3%	AU$653.3m	AU$8.75	PS29.6x	E36.8%	n/a
CU6 Clarity Pharmaceuticals	AU$4.00	-22.6%	110.5%	AU$1.3b	AU$8.67	PS111.3x	E36.7%	n/a
PIQ Proteomics International Laboratories	AU$0.61	-5.4%	-28.1%	AU$80.6m	n/a	PS24.6x	E28.8%	n/a
CUV Clinuvel Pharmaceuticals	AU$12.15	1.3%	-25.9%	AU$606.9m	AU$28.29	PE17x	E26.2%	0.4%
SNT Syntara	AU$0.067	8.1%	191.3%	AU$105.8m	n/a	PS18.4x	E25.3%	n/a
PER Percheron Therapeutics	AU$0.007	0%	-88.1%	AU$7.4m	n/a	PS2.5x	E24.7%	n/a
IMC Immuron	AU$0.08	-2.4%	2.6%	AU$18.3m	n/a	PS3.7x	E22.4%	n/a
RCE Recce Pharmaceuticals	AU$0.46	-1.1%	-4.2%	AU$106.7m	AU$2.46	PS21.2x	E18.3%	n/a
EZZ EZZ Life Science Holdings	AU$3.17	7.8%	395.3%	AU$146.3m	AU$5.45	PE21x	E17.9%	0.9%